Target intelligence / Profile preview

Histocompatibility 2, class II antigen A, alpha (H2-Aa) (H2-Aa)

Target
H2-Aa
Molecular classification
MHC class II protein, Antigen-presenting molecule, Receptor
01

Overview

Histocompatibility 2, class II antigen A, alpha (H2-Aa) is a protein-coding gene in mice that encodes the alpha chain of the I-A molecule, a member of the major histocompatibility complex (MHC) class II family (UniProt P04224). It is primarily expressed on the surface of professional antigen-presenting cells, such as dendritic cells, B cells, and macrophages, where it forms a heterodimer with the H2-Ab1 beta chain (NCBI Gene 14960). The primary biological function of H2-Aa is to bind and present processed exogenous peptides to the T-cell receptors (TCR) of CD4+ T helper cells, a process fundamental to the initiation of the adaptive immune response. In disease contexts, H2-Aa is heavily involved in the pathogenesis of autoimmune disorders, where the presentation of self-peptides can trigger aberrant immune attacks (PubMed: 25607456). It also plays a critical role in the immune system's ability to recognize and respond to infectious pathogens and tumor-associated antigens. While H2-Aa itself is often a target of research-grade monoclonal antibodies like M5/114.15.2 to study immune modulation, its human orthologs (HLA-DQ) are significant targets for developing therapies for allergies and transplant rejection. Understanding the structural and functional nuances of H2-Aa is essential for the design of vaccines and immunotherapies that aim to either enhance or suppress specific immune pathways.

Other names
I-A alphaMHC class II antigen A alphaH-2 class II antigen A alphaIAaH2-IAAI323765
02

Mechanism of action

Presentation of exogenous peptides to CD4+ T-cell receptors to initiate adaptive immune responses.

03

Biological functions

Antigen processing and presentationT cell activationAdaptive immune responseImmune signaling
04

Disease associations

Autoimmune diseaseInfectionCancerGraft-versus-host diseaseAllergy
05

Safety considerations

Systemic immunosuppressionInduction of autoimmunityImpaired response to infections
06

Interacting drugs

M5/114.15.2 (monoclonal antibody)

3 more in the full profile.

07

Biomarkers

MHC II surface expression levelsCD4+ T cell activation markersH2-Aa mRNA expression

Beyond the preview

Go deeper on Histocompatibility 2, class II antigen A, alpha (H2-Aa) (H2-Aa).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Histocompatibility 2, class II antigen A, alpha (H2-Aa) (H2-Aa).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call